Infertility / Andrology / Endocrinology Flashcards
Normal parameters for semen assessment;
1. Semen volume
2. PH
3. Sperm Concentration
4. Total sperm number
5. Total motility
6. Vitality
7. Sperm morphology
- Greater than it equal to 1.5ml
- pH > or equal to 7.2
- > or = to 15 million sperm/ml
- 39 million sperm per ejaculate or more
- 40% or more motile or 32% with progressive motility
- 58% or more live sperm
- 4% or more normal
Azoospermia on single semen sample?
What to do if abnormalities persist?
Repeat semen sample in 3 months.
If abnormalities persist, then the male partner will need hormone profiling to look for hypogonadotrophic hypogonadism which can potentially be treated with gonadotropins.
First line management for couples with endometriosis and subfertility ?
ART in the form of IUI with Ovarian Stimulation.
Effect of cystectomy for endometriomas on ART ?
Cystectomy is associated with poorer response to stimulation and greater risk of cycle cancellation compared to no surgery (13.7% vs 0%)
Precocious Puberty
- Define
- Features
- What % is idiopathic
- Onset of pubertal development < 8 years of age
- 5-8x more common in girls than boys
- 75% is idiopathic
- NOT associated with premature menopause and reproductive life is normal
- Children are transiently tall but there is early epiphyseal fusion resulting in short stature
- Intellectual and psychological development consistent with chronological age
What are the 2 types of precocious puberty?
- GnRH Dependent - early activation of the hypothalamic - pituitary - gonadal axis
- GnRh Independent - incomplete, peripheral, precocious pseudo-puberty
Causes of GnRH dependent precocious puberty ?
- Idiopathic - 74% girls
- CNS Abnormality, include:
a) SOL - glioma, hamartoma, hydrocelpalus
b) Infection - post encephalitis, brain abscess, meningitis
c) Head Injury/ Irradiation
d) Tuberous Sclerosis and Neurofibromatosis
e) Late/Incompletely Treated CAH
Causes of GnRH independent precocious puberty?
- Topical/ systemic androgens or oestrogens
- Tumours - Ovarian (in 10% of girls with precocious puberty - granuloma, theca cell tumours), Adrenal (rare and associated with increased DHEA-S)
- Severe Hypothyroidism - TSH has LH and FSH activity
- McCune-Albright Syndrome
- CAH
McCune Alrbight Syndrome (polyostotic fibrous dysplasia)
- Gene mutation - not inherited
- 5% female precocity
- Bone cysts, pathological fractures, cafe-au-lait spots, sexual precocity
- Early production of oestrogens by the ovaries
- Fertility and adult height are normal
Testosterone is bound to?
- Sex hormone binding globulin and is metabolically inactive - 85%
- 10-15% bound to Ablumin
- 1-2% free
Free and albumin bound testosterone is metabolically active.
Testosterone is converted to the biologically active .. by ..
- Dihydrotestosterone
- 5-alpha reductase
Increased activity of this enzyme may cause manifestations of androgen excess.
List causes of hyperandrogenism
- Exogenous/Iatrogenic - testosterone, anabolic steroids, danazol
- Ovarian - PCOS, Ovarian tumours (sertoli-leydig, Krukenburg tumours)
- Adrenal tumours, Cushing’s syndrome, adult onset CAH
- Androgen excess in Pregnancy - luteoma
- Idiopathic Hirtuism
- Abnormal gonadal/ sexual development
Investigations for hyperandrogenism
- Increased testosterone = ovarian
Increased DHEAS = adrenal
**Markedly elevated testosterone should prompt investigation for virilising tumour **
- If history + exam convincing of Cushing’s Syndrome - for overnight dexamethasone suppression test
- Late onset CAH - 17 hydroxyprogesterone levels after ACTH stimulation
- Pelvic US - ovarian mass/ PCOS
- CT/MRI - adrenal tumour
- Karyotype if virilisation
- Consider serum lipids + GTT
Ovarian Hyperthecosis
Rare Disorder
Severe hyperandrogenism and insulin resistance
Postmenopausal women
Associated with large islands of luetinised theca cells throughout the ovarian stoma with increased androgen production
Peripheral oestrogen also increased - risk of endometrial hyperplasia/ carcinoma
IMPORTANT Ddx in POSTMENOPAUSAL WOMAN WITH VIRILISATION / TESTOSTERONE >5
Rotterdam Criteria for PCOS diagnosis?
2 of 3:
1. Polycystic Ovaries (>12 peripheral follicles or increased ovarian volume >10cm3)
- Oligo- or anovulation
- Clinical and or biochemical signs of hyperandrogenism
Recommended baseline screening tests when investigating PCOS?
- TFT
- Serum Prolactin
- Free Androgen Index (total testosterone/SHBG x100)
In the presence of hyperandrogenism and testosterone >5:
1. 17-hydroxyprogesterone
2. Exclude androgen secreting tumours
Prevalence of PCOS?
6-7%
Biochemical derangements in PCOS
- Raised androgens - testosterone from ovarian hyper secretion, 50% of women with PCOS will have elevated DHEAS
- Inc concentrations of free Oestradiol
- Decreased SHBG production by the liver resulting in higher free, biologically active androgens and estradiol
- Hyperprolactinaemia (20%, mild)
- LH Hypersectretion - 40% women with PCOS, thought to be associated with reduced chance of conception and increased chance of miscarriage
- Insulin resistance - 30 - 60%
Long term sequelae of PCOS?
- Insulin Resistance - 40% NIDDM by age 40
- Sleep Apnoea
- Multiple pregnancy from ovulation induction
- PIH - independent of obesity and GDM
- Endometrial cancer (5 fold) - if > 3 months between menses
- Cardiovascular Disease
Management of menstrual irregularity in PCOS?
Loss of 10% body weight alone may result in return to regular ovulation + menses.
COCP - use non androgenic progestogen (avoid norethisterone/ levonorgestrel) or cyproterone acetate
Alternatively medroxyprogesterone acetate 5-10 days every 1-3 months to induce withdrawal bleed
Metabolic Syndrome - diagnostic criteria
3/5 of the following:
1. Abdominal Obesity
2. Hypertriglyceridaemia
3. Low HDL Cholesterol
4. Hypertension
5. High Fasting Glucose
Pharmacological Methods to manage Hirtuism?
- COCP - suppressed LH production and ovarian androgen synthesis. Avoid androgenic progestogens (norethisterone/ levonorgestrel). Try cyproterone acetate. Use with contraceptive as can emasculate a male fetus.
- Medroxyprogesterone Acetate - in those COCP contraindicated
- Spironalactone - anti androgen and aldosterone effect
- Flutamide - non steroidal antiandrogen, check LFTs
- Finasteride - 5 alpha reductase inhibitor
- Ketoconazole - significant hepatotoxicity
Causes of Primary Amenorrhoea?
- Abnormal Karyotype eg Turners
- Abnormal CNS-Hypothalamic response (eg. Kallmans Syndrome, anorexia nervosa)
- Abnormal Pituitary Function (eg. Pituitary tumour, prolacinoma)
- Gonadal/ Adrenal Abnormalities (eg. late onset CAH, gonadal genesis, galactosaemia, POF)
Kallman Syndrome
X linked recessive
Delayed/absent puberty (hypogonadotrophic hypogonadism)
Impaired sense of smell
Cleft palate
1/120,000 females
Androgen Insensitivity Syndrome
- Most present after puberty
- 46 XY karyotype
- Short, blind ending vagina, absent uterus and cervix
- Testes found within abdomen, inguinal canal, labia
- Inc risk of cancer in testes - recommend gonadectomy after puberty
5 alpha reductase deficiency
- Autosomal recessive
- Poor masculinisation of external genetalia in male fetus
- Uterus, tubes and vagina absent
Primary amenorrhoea + elevated FSH + 46XX karyotype.
What further investigations are required?
U&E/ serum progesterone to exclude 17- alpha hydroxylase deficiency (RARE)
- Hypokalaemia
- Hypernatraemia
- Elevated serum Progesteroje
- Low 17 hydroxy progesterone
Need cortisol replacement + oestrogen and progesterone HRT
Primary amenorrhoea + 46XX karyotype + low FSH.
What further investigations are required?
Serum Prolactin + cranial CT scan to exclude Prolactinoma.
If normal CT/Prolactin- use oestrogen and progesterone to induce breast development and GnRH to induce ovulation when fertility required.
Clomiphene citrate ineffective.
Primary amenorrhoea + normal breast development + absent uterus.
Causes?
- Mullerian Agenesis - normal body hair with cyclical ovulating symptoms, normal female testosterone levels. Need renal scan to exclude renal tract abnormalities.
- Androgen Insensitivity - 46XY + male testosterone levels. Go addicting after puberty + oestrogen replacement
Causes of Hyper-Prolactinaemia?
- Hypothalamic - lesions which disrupt portal circulation of dopamine to pituitary. Craniophyringioma is the commonest
- Pituitary
- Prolactin secreting adenoma
- Acromegaly (25%)
- Cushings (10%)
- Empty Sella Syndrome - Drugs
- Psychotropic agents, diazepam, tricyclic antidepressants, opiates, haloperidol
- Methyldopa, propranolol
- Metoclopramide
- COCP - Primary Hypothyroidism
- Associated with increased thyrotropin releasing hormone which stimulates prolactin release
3-5% of women with hyper prolactinaemia have HypoT.
What % of pituitary tumours secrete Prolactin?
80%
Define micro adenoma vs macro adenoma
Micro-Adenoma: <10mm diameter
Macro-Adenoma: >10mm diameter
If Prolactin < 1000IU/L - investigations? possible causes?
Exclude:
1. Stress
2. Recent breast exam
3. Drug induced
Repeat test + TSH to exclude hypothyroidism.
PCOS may be associated with levels up to 2500IU/L - organise Pelvic US.
If Prolactin > 1000IU/L - investigations? possible causes?
Prolactin levels:
1. Micro adenoma
2. Macro adenoma
CT/MRI of pituitary fossa.
Macro-adenoma usually associated with Prolactin levels > 5000IU/L.
Micro adenomas usually associated with levels 1500-4000IU/L
First line medical treatment for hyper prolactinaemia secondary to pituitary adenoma?
Mechanism of action?
SE’s?
Bromocriptine
Dopamine Agnoist
Nausea, vomiting, headache, postural hypotension, constipation, dizziness, drowsiness, Raynaud’s, psychiatric phenomenon
Avoid breastfeeding!
Second linemedical treatment for hyper prolactinaemia secondary to pituitary adenoma?
Mechanism of action?
SE’s?
Cabergoline
Long acting dopamine agonist
Dispepsia, abdominal pain, nausea, breast pain, palpitations, nose bleeds, angina, depression, hot flushes
Prolacinoma and pregnancy?
Ovulation induction by which method?
Anterior pituitary enlarges in Pregnancy as a result of lactotroph hyperplasia with resultant increase in serum prolactin (10-20x)
Ovulation induction with Bromocriptine required in most Women.
Risk of symptoms in Pregnancy in women with micro-prolactinomas?
2-5%